UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039440
Receipt number R000044965
Scientific Title Investigation of the occult-bacterial translocation induced by surgical stress
Date of disclosure of the study information 2020/03/01
Last modified on 2020/02/09 17:44:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the occult-bacterial translocation induced by surgical stress

Acronym

O-BT induced by surgical stress

Scientific Title

Investigation of the occult-bacterial translocation induced by surgical stress

Scientific Title:Acronym

O-BT induced by surgical stress

Region

Japan


Condition

Condition

Patients undergoing highly invasive abdominal surgery.

Classification by specialty

Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the incidence of occult-bacterial translocation induced by surgical stress.

Basic objectives2

Others

Basic objectives -Others

To investigate the impact of occult-bacterial translocation on postoperative course.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

The incidence of occult-bacterial translocation induced by surgical stress and its impact on postoperative course.

Key secondary outcomes

The association of the preoperative intestinal microenvironment and the incidence of occult-bacterial translocation.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Collect fecal sample before surgery.
Collect blood sample immediately after the induction of general anesthesia and after the completion of surgery.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are going to undergo highly invasive abdominal surgery as the followings:
* Major hepatectomy (with and without extrahepatic bile duct resection)
* Pancreatoduodenectomy
* Hepatopancreatoduodenectomy
* Distal pancreatectomy with celiac axis resection
* Subtotal esophagectomy
* Other surgeries, which are considered highly invasive by the primary investigator

Key exclusion criteria

* Patients who reject participation for this study

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Yukihiro
Middle name
Last name Yokoyama

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Surgery, Division of Surgical Oncology

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

0527442222

Email

yyoko@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Yukihiro
Middle name
Last name Yokoyama

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Surgery, Division of Surgical Oncology

Zip code

4668550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

0527442222

Homepage URL


Email

yyoko@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nagoya University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Ethics Committee

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japana

Tel

0527442061

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 02 Month 09 Day

Date of IRB

2020 Year 02 Month 03 Day

Anticipated trial start date

2020 Year 03 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 02 Month 09 Day

Last modified on

2020 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044965


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name